PROSTATE CARCINOMA
Clinical trials for PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tiny beads tested to shrink prostate, ease symptoms before cancer treatment
Disease control OngoingThis study is testing a procedure called prostatic artery embolization (PAE) in men with early-stage prostate cancer who have bothersome urinary symptoms and are planning to get radiation therapy. Doctors inject tiny particles to block blood flow to the prostate, aiming to shrink…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Could your morning tea help control prostate cancer?
Disease control OngoingThis study is testing whether a concentrated green tea extract can help prevent low-risk prostate cancer from getting worse. It involves 360 men who are on active surveillance, meaning they are monitoring their cancer instead of treating it right away. Participants will take eith…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Doctors use advanced scans to watch radiation zap prostate tumors
Disease control OngoingThis study aims to see if MRI scans taken 6-9 months after precise radiation treatment can show how well prostate cancer tumors are responding. Researchers will compare these scan results with standard blood tests (PSA) in 28 men with intermediate to high-risk prostate cancer. Th…
Matched conditions: PROSTATE CARCINOMA
Sponsor: University of Zurich • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo tested to tame deadly prostate cancer
Disease control OngoingThis study is testing if adding the drug olaparib after standard chemotherapy helps control a fast-growing, hard-to-treat form of prostate cancer. About 96 men with advanced, aggressive prostate cancer that has spread will receive chemotherapy, then some will receive olaparib pil…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Phone-Based support aims to bridge gap for rural cancer survivors
Disease control OngoingThis study is testing whether a combination of tools can help cancer survivors living in rural areas better manage their health after treatment ends. Participants create their own survivorship care plan and some receive a phone-based education session. The goal is to see if this …
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for High-Risk prostate cancer: drug combo aims to block deadly spread
Disease control OngoingThis study is for men with high-risk prostate cancer who have had surgery to remove the prostate. It tests whether adding a new drug called darolutamide to standard hormone-blocking therapy is better at preventing the cancer from spreading to other parts of the body. The goal is …
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Comfortable scan could sharpen prostate cancer pictures
Diagnosis OngoingThis study is testing a new type of 3D MRI scan for men with prostate cancer. The goal is to see if this new scan can create clear pictures of the prostate without requiring an uncomfortable rectal coil during the procedure. Researchers will compare the image quality of the new 3…
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Apr 01, 2026 21:41 UTC
-
Advanced scans aim to pinpoint deadly prostate cancer before the knife
Diagnosis OngoingThis study is testing whether a special type of MRI scan can help doctors more accurately determine how aggressive a man's prostate cancer is before he has surgery. The goal is to see if these detailed images, combined with other test results, can create a better prediction model…
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
New scan aims to end prostate cancer biopsy guesswork
Diagnosis OngoingThis study is testing a new way to find prostate cancer in men whose previous biopsy results were unclear or negative. Researchers are using a special radioactive tracer that sticks to prostate cancer cells, which shows up on a PET/CT scan. This scan then guides the doctor's biop…
Matched conditions: PROSTATE CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
New scan aims to pinpoint dangerous prostate cancer
Diagnosis TerminatedThis study aimed to test a new type of imaging scan to see if it could better identify aggressive prostate cancer. It planned to compare a special PET/MRI scan to a standard MRI scan in men with elevated PSA levels who were scheduled for a biopsy. The goal was to improve the accu…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
New cancer scanner aims to reduce radiation planning visits
Diagnosis OngoingThis study is testing a new type of imaging machine for men with prostate cancer. Researchers want to see if the pictures it takes are as good as the current standard scan. If successful, this machine could allow doctors to plan a patient's radiation therapy using the same scan, …
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Mar 30, 2026 14:31 UTC
-
Could a simple ultrasound scan replace prostate biopsies?
Diagnosis OngoingThis study is testing whether a special type of ultrasound can accurately find prostate cancer. Men scheduled for prostate removal surgery receive a safe, short-lived contrast agent and then have an ultrasound scan. Researchers will compare the ultrasound images to the actual pro…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
One-Step prostate scan and biopsy device under investigation
Diagnosis TerminatedThis study is testing whether a new device called the OmnEcoil system can safely combine two prostate cancer detection steps into one procedure. Currently, men with suspicious prostate findings typically get an MRI scan first, then return later for a separate biopsy. This device …
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Mar 17, 2026 13:09 UTC
-
New scan aims to better spot spreading prostate cancer
Diagnosis OngoingThis study is testing if a special full-body MRI scan is better than the standard combination of bone and CT scans at finding out if high-risk prostate cancer has spread to the bones or lymph nodes. Men with high-risk prostate cancer will receive both the new MRI scan and the sta…
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Mar 11, 2026 14:54 UTC
-
New MRI technique aims for sharper prostate cancer pictures
Diagnosis OngoingThis study is testing if a modified type of MRI scan can create better images of prostate cancer than the standard MRI. The goal is to help doctors see the cancer more clearly before a patient has surgery to remove the prostate. Men with confirmed prostate cancer who are schedule…
Matched conditions: PROSTATE CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Mar 04, 2026 15:29 UTC
-
New combo therapy aims to fight debilitating cancer fatigue
Symptom relief OngoingThis study is testing whether combining a stimulant medication (methylphenidate) with a structured exercise program works better than exercise alone to reduce severe, persistent fatigue in men with prostate cancer. It involves about 200 patients who are starting radiation and hor…
Matched conditions: PROSTATE CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Mayo clinic tests if emptying your bladder before radiation eases side effects
Symptom relief OngoingThis study compares two ways to prepare for prostate cancer radiation therapy: coming with a full bladder or an empty bladder. The standard method requires a full bladder, but this can be difficult for patients to maintain and may cause stress. Researchers want to see if using an…
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 25, 2026 14:07 UTC
-
Doctors test virtual tool to improve prostate cancer genetics discussions
Knowledge-focused OngoingThis study is testing a web-based virtual meeting tool designed to help healthcare providers discuss prostate cancer genetics cases. Doctors and other providers use the tool to talk about genetic testing, personalized treatment options, and screening recommendations. Researchers …
Matched conditions: PROSTATE CARCINOMA
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Researchers probe hidden factors in immigrant cancer care
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how immigration experiences affect prostate cancer care decisions and survivorship for men from Sub-Saharan Africa and the Caribbean. Researchers will interview 80 immigrant men who have been diagnosed with prostate cancer to learn about their health…
Matched conditions: PROSTATE CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Scientists scan hearts to uncover hidden side effects of prostate cancer treatment
Knowledge-focused OngoingThis small study aims to understand how hormone therapy for prostate cancer affects heart function and muscle health. Researchers will use special heart scans and muscle tests on 23 patients before they start treatment and again 4-7 months later. The goal is to gather information…
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
Major study seeks genetic clues to why younger people get cancer
Knowledge-focused TerminatedThis study aims to understand why certain cancers develop at younger ages in people from different racial and ethnic backgrounds. Researchers will collect tumor tissue and blood samples from 2,400 patients during their regular cancer surgeries. By analyzing these samples, they ho…
Matched conditions: PROSTATE CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
New web tool aims to decode cancer genetics for patients
Knowledge-focused OngoingThis study is testing a web-based education tool called HOPE-Genomics to see if it helps cancer patients better understand their personal genetic test results and general cancer genomics. Researchers are comparing the tool's effectiveness against standard education methods in abo…
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Scientists track Cancer's 'Fingerprints' after surgery
Knowledge-focused OngoingThis study aims to understand if tiny particles released by prostate cancer cells, found in blood and urine, change after surgery and if they relate to standard blood test results. Researchers will collect samples from about 100 men with prostate cancer before and after their sur…
Matched conditions: PROSTATE CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC
-
Massive study follows 2500 men after prostate cancer surgery
Knowledge-focused OngoingThis study tracks the long-term health of prostate cancer survivors who had surgery at least one year ago. Researchers follow 2500 men to understand their quality of life, potential complications, and overall health after treatment. The information gathered will help improve futu…
Matched conditions: PROSTATE CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:23 UTC
-
Scientists hunt genetic clues in prostate cancer families
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how inherited gene mutations affect prostate cancer risk and treatment. Researchers are enrolling 1,360 men with prostate cancer and their family members to collect saliva samples and health information. The goal is to identify patterns that could le…
Matched conditions: PROSTATE CARCINOMA
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:24 UTC